Other institutions, including Mariner and Ameritas Investment Partners, also increased exposure to the stock. ・Sellas said on Tuesday that its Phase 3 Regal AML study had reached 78 events as of May ...
NASA just revealed some new details about its upcoming Artemis 3 astronaut mission to Earth orbit, which is targeted to ...
NASA may pivot Artemis III to an Earth-orbit test mission, potentially delaying the next crewed Moon landing to the Artemis ...
Artemis III is currently targeted for late 2027, and NASA has shared some of its plans for the mission, though exactly how ...
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer ...